2-Hydroxytetradec-9-enoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-Hydroxytetradec-9-enoic acid
• 英文别名: 2-hydroxytetradec-9-enoic acid
• 化学式: C₁₄H₂₆O₃
• 分子量: 242.35
• InChiKey: XHLPHPANAJCBET-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  17
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.79
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• PHARMACEUTICAL FORMULATION COMPRISING DICLOFENAC AND A HYDROXY FATTY ACID POLYOXYALKYLENE ESTER
  申请人：Advance Holdings Limited

  公开号：EP2364140A1

  公开（公告）日：2011-09-14
• PHARMACEUTICAL FORMULATION COMPRISING KETOPROFEN AND A POLYOXYALKYLENE ESTER OF A HYDROXY FATTY ACID
  申请人：Advance Holdings Limited

  公开号：EP2405892A1

  公开（公告）日：2012-01-18
• TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING HEPARIN
  申请人：Advance Holdings Limited

  公开号：EP2566457A1

  公开（公告）日：2013-03-13
• PHARMACEUTICAL FORMULATION COMPRISING DICLOFENAC
  申请人：Virno Michele

  公开号：US20110275717A1

  公开（公告）日：2011-11-10

  The present invention relates to a pharmaceutical formulation comprising a pharmaceutically acceptable salt of diclofenac, at least one polyoxyalkylene ester of a hydroxy fatty acid, water, and, optionally, a co-solvent.
• [EN] PHARMACEUTICAL FORMULATION COMPRISING DICLOFENAC AND A HYDROXY FATTY ACID POLYOXYALKYLENE ESTER<br/>[FR] FORMULE PHARMACEUTIQUE COMPRENANT DU DICLOFÉNAC ET UN ESTER DE POLYOXYALKYLÈNE D'HYDROXYACIDE GRAS
  申请人：ADVANCE HOLDINGS LTD

  公开号：WO2010060798A1

  公开（公告）日：2010-06-03

  The present invention relates to a pharmaceutical formulation comprising a pharmaceutically acceptable salt of diclofenac, at least one polyoxyalkylene ester of a hydroxy fatty acid, water, and, optionally, a co-solvent.